Autoantibodies in Type 1 diabetes

Autoantibodies, and the antigens they recognise, are potentially valuable in the prediction and prevention respectively of type 1 diabetes as well as in the classification of autoimmune diabetes. Screening the general population for type 1 diabetes susceptibility is now feasible. Trials to prevent type 1 diabetes using disease-associated autoantigens are now in progress.